Doses to Internal Organs for Various Breast Radiation Techniques--implications on the Risk of Secondary Cancers and Cardiomyopathy

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2011 Jan 18

PMID 21235766

Citations 15

Authors

Jean-Philippe Pignol

Brian M Keller

Ananth Ravi

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancers are more frequently diagnosed at an early stage and currently have improved long term outcomes. Late normal tissue complications induced by adjuvant radiotherapy like secondary cancers or cardiomyopathy must now be avoided at all cost. Several new breast radiotherapy techniques have been developed and this work aims at comparing the scatter doses of internal organs for those techniques.

Methods: A CT-scan of a typical early stage left breast cancer patient was used to describe a realistic anthropomorphic phantom in the MCNP Monte Carlo code. Dose tally detectors were placed in breasts, the heart, the ipsilateral lung, and the spleen. Five irradiation techniques were simulated: whole breast radiotherapy 50 Gy in 25 fractions using physical wedge or breast IMRT, 3D-CRT partial breast radiotherapy 38.5 Gy in 10 fractions, HDR brachytherapy delivering 34 Gy in 10 treatments, or Permanent Breast 103Pd Seed Implant delivering 90 Gy.

Results: For external beam radiotherapy the wedge compensation technique yielded the largest doses to internal organs like the spleen or the heart, respectively 2,300 mSv and 2.7 Gy. Smaller scatter dose are induced using breast IMRT, respectively 810 mSv and 1.1 Gy, or 3D-CRT partial breast irradiation, respectively 130 mSv and 0.7 Gy. Dose to the lung is also smaller for IMRT and 3D-CRT compared to the wedge technique. For multicatheter HDR brachytherapy a large dose is delivered to the heart, 3.6 Gy, the spleen receives 1,171 mSv and the lung receives 2,471 mSv. These values are 44% higher in case of a balloon catheter. In contrast, breast seeds implant is associated with low dose to most internal organs.

Conclusions: The present data support the use of breast IMRT or virtual wedge technique instead of physical wedges for whole breast radiotherapy. Regarding partial breast irradiation techniques, low energy source brachytherapy and external beam 3D-CRT appear safer than 192Ir HDR techniques.

Citing Articles

Genome-wide DNA methylation regulation analysis provides novel insights on post-radiation breast cancer.

Ji J, Li D, Zhao X, Wang Y, Wang B Sci Rep. 2025; 15(1):5641.

PMID: 39955415 PMC: 11830005. DOI: 10.1038/s41598-025-90247-1.

External-Beam-Accelerated Partial-Breast Irradiation Reduces Organ-at-Risk Doses Compared to Whole-Breast Irradiation after Breast-Conserving Surgery.

Ott O, Stillkrieg W, Lambrecht U, Schweizer C, Lamrani A, Sauer T Cancers (Basel). 2023; 15(12).

PMID: 37370738 PMC: 10296368. DOI: 10.3390/cancers15123128.

Dose to contralateral breast from whole breast irradiation by automated tangential IMRT planning: comparison of flattening-filter and flattening-filter-free modes.

Ogino I, Seto H, Shigenaga D, Hata M Rep Pract Oncol Radiother. 2022; 27(1):113-120.

PMID: 35402036 PMC: 8989456. DOI: 10.5603/RPOR.a2022.0006.

Phrenic Nerve Palsy Following Radiation Therapy for Patient With Breast Cancer.

Sharma A, Raziq F, Kemnic T, Prasad R Perm J. 2022; 25.

PMID: 35348081 PMC: 8784065. DOI: 10.7812/TPP/20.313.

Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers.

Pignol J, Hoekstra N, Wilke D, Dahn H, Nolan M, Vicini F Front Oncol. 2021; 11:713328.

PMID: 34434899 PMC: 8381359. DOI: 10.3389/fonc.2021.713328.

References

Fuller S, Haybittle J, Smith R, Dobbs H . Cardiac doses in post-operative breast irradiation. Radiother Oncol. 1992; 25(1):19-24. DOI: 10.1016/0167-8140(92)90190-6. View

Vicini F, Kestin L, Chen P, Benitez P, Goldstein N, Martinez A . Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003; 95(16):1205-10. DOI: 10.1093/jnci/djg023. View

Wazer D, Berle L, Graham R, Chung M, Rothschild J, Graves T . Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002; 53(4):889-97. DOI: 10.1016/s0360-3016(02)02824-9. View

Veronesi U, Orecchia R, Luini A, Galimberti V, Gatti G, Intra M . Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg. 2005; 242(1):101-6. PMC: 1357710. DOI: 10.1097/01.sla.0000167927.82353.bc. View

Tubiana M . Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol. 2009; 91(1):4-15. DOI: 10.1016/j.radonc.2008.12.016. View

Stovall M, Smith S, Langholz B, Boice Jr J, Shore R, Andersson M . Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008; 72(4):1021-30. PMC: 3782859. DOI: 10.1016/j.ijrobp.2008.02.040. View

Lymperopoulou G, Papagiannis P, Angelopoulos A, Karaiskos P, Georgiou E, Baltas D . A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities. Med Phys. 2007; 33(12):4583-9. DOI: 10.1118/1.2392408. View

Keisch M, Vicini F, Kuske R, Hebert M, White J, Quiet C . Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003; 55(2):289-93. DOI: 10.1016/s0360-3016(02)04277-3. View

Elkin E, Hudis C, Begg C, Schrag D . The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer. 2005; 104(6):1149-57. DOI: 10.1002/cncr.21285. View

10.

Pignol J, Rakovitch E, Keller B, Sankreacha R, Chartier C . Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study. Int J Radiat Oncol Biol Phys. 2008; 73(5):1482-8. DOI: 10.1016/j.ijrobp.2008.06.1945. View

11.

Lessard E, Pouliot J . Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med Phys. 2001; 28(5):773-9. DOI: 10.1118/1.1368127. View

12.

Zablotska L, Neugut A . Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003; 97(6):1404-11. DOI: 10.1002/cncr.11214. View

13.

Xu X, Bednarz B, Paganetti H . A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol. 2008; 53(13):R193-241. PMC: 4009374. DOI: 10.1088/0031-9155/53/13/R01. View

14.

Woo T, Pignol J, Rakovitch E, Vu T, Hicks D, OBrien P . Body radiation exposure in breast cancer radiotherapy: impact of breast IMRT and virtual wedge compensation techniques. Int J Radiat Oncol Biol Phys. 2006; 65(1):52-8. DOI: 10.1016/j.ijrobp.2005.11.023. View

15.

Rivard M, Davis S, DeWerd L, Rusch T, Axelrod S . Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray Source: an electronic brachytherapy source. Med Phys. 2006; 33(11):4020-32. DOI: 10.1118/1.2357021. View

16.

Bethune W . Partial breast irradiation for early breast cancer. J Natl Med Assoc. 1991; 83(9):768, 800, 808. PMC: 2627101. View

17.

Darby S, McGale P, Taylor C, Peto R . Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6(8):557-65. DOI: 10.1016/S1470-2045(05)70251-5. View

18.

Hall E . Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006; 65(1):1-7. DOI: 10.1016/j.ijrobp.2006.01.027. View

19.

Peto R, Boreham J, Clarke M, Davies C, Beral V . UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000; 355(9217):1822. DOI: 10.1016/S0140-6736(00)02277-7. View

20.

Vicini F, Remouchamps V, Wallace M, Sharpe M, Fayad J, Tyburski L . Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003; 57(5):1247-53. DOI: 10.1016/s0360-3016(03)01573-6. View